Abstract
The flavone moiety is a potential pharmacophore known for its diverse range of pharmacological activities. Aminoflavones have recently been the subject of considerable attention as lead molecules in several cancer research projects. Imidazolidinone heterocycles represent another biologically active scaffold with known cytotoxic properties. In an attempt to provide synergistic cytotoxic activity, these two moieties have been combined, and the resulting novel analogues evaluated for their anticancer and anti-inflammatory activities. The results revealed that the cytotoxicities of these compounds were fivefold greater than those of aminoflavone. DNA histograms obtained from cell cycle analysis in the presence of these compounds were apoptotic in their nature. Furthermore, the in vivo screening of these compounds using Ehrlich’s ascites tumour model showed an increase in life span, whereas an in vivo anti-inflammatory study resulted in the enhancement of the anti-inflammatory potential. The results therefore supported the hypothesis that there is a relationship between inflammation and cancer.
Similar content being viewed by others
References
Akama T, Ishida H, Shida Y, Kimura U, Gomi K, Saito H, Fuse E, Kobayashi S, Yoda N, Kasai M (1997) Design and synthesis of potent antitumor 5,4′-diaminoflavone derivatives based on metabolic considerations. J Med Chem 40(12):1894–1900
Al-Madi SH, Al-Obaid AM, EI-Subbagh HI (2001) The in vitro antitumor assay of 5-(Z)-arylidene-4-imidazolidinones in screens of AIDS-related leukemia and lymphomas. Anticancer Drugs 12(10):835–839
Brian SF, Antony JH, Smith Peter WG, Austin RT (1989) Vogel’s Textbook of practical organic chemistry. Longman Scientific & Technical, England
Chen L, Watkins JF (1970) Evidence against the presence of H2 histocompatibility antigens in Ehrlich ascites tumour cells. Nature 225(5234):734–735
Chern JH, Shia KS, Chang CM, Lee CC, Lee YC, Tai CL, Lin YT, Chang CS, Tseng HY (2004) Synthesis and in vitro cytotoxicity of 5-substituted 2-cyanoimino-4-imidazodinone and 2-cyanoimino-4-pyrimidinone derivatives. Bioorg Med Chem Lett 14(5):1169–1172
Cushman M, Zhu H, Geahlen RL, Kraker AJ (1994) Synthesis and biochemical evaluation of a series of aminoflavones as potential inhibitors of protein-tyrosine kinases p56lck, EGFr, and p60v-src. J Med Chem 37(20):3353–3362
Denizot F, Lang R (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89(2):271–277
Devi PU, Rao BS, Solomon FE (1998) Effect of plumbagin on the radiation induced cytogenetic and cell cycle changes in mouse Ehrlich ascites carcinoma in vivo. Indian J Exp Biol 36(9):891–895
Duvall E, Wyllie AH (1986) Death and the cell. Immunol Today 7(4):115–119
Ferte J, Kuhnel JM, Chapuis G, Rolland Y, Lewin G, Schwaller MA (1999) Flavonoid-related modulators of multidrug resistance: synthesis, pharmacological activity, and structure–activity relationships. J Med Chem 42(3):478–489
Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wahala K, Montesano R, Schweigerer L (1997) Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 57(14):2916–2921
Ghosh MN (1984) Toxicity studies: fundamentals of Experimental Pharmacology. Scientific Book Agency, Calcutta
Hu YW, Liu CY, Du CM, Zhang J, Wu WQ, Gu ZL (2009) Induction of apoptosis in human hepatocarcinoma SMMC-7721 cells in vitro by flavonoids from Astragalus complanatus. J Ethnopharmacol 123(2):293–301
Jung SH, Lee HS, Song JS, Kim HM, Han SB, Lee CW, Lee M, Choi DR, Lee JA, Chung YH, Yoon SJ, Moon EY, Hwang HS, Seong SK, Lee DK (1998) Synthesis and antitumor activity of 4-phenyl-1-arylsulfonyl imidazolidinones. Bioorg Med Chem Lett 8(12):1547–1550
Jung SH, Park KL, Lee HS, Whang JS (2001) Evaluation of the role of imidazolidinone motif of antineoplastic 4-phenyl-1-arylsulfonylimidazolidinones using 4-phenyl-2-arylsulfonyloxazolines. Arch Pharm Res 24(6):499–502
Khaksari M, Mahani SE, Mahmoodi M (2004) Calcium chanel blockers reduce inflammatory edema in the rat. Indian J Pharmacol 36(6):351–354
Khodair AI, El-subbagh HI, Al-obaid AM (1998) Synthesis, conformational analysis and antitumor testing of 5-(Z)-arylidene-4-imidazolidinone derivatives. Phosphorus Sulfur Silicon Relat Elem 140(1):159–181
Kim IW, Jung SH (2002) Recognition of the importance of imidazolidinone motif for cytotoxicity of 4-phenyl-1-arylsulfonylimidazolidinones using thiadiazolidine-1,1-dioxide analogs. Arch Pharm Res 25(4):421–427
Kuffel MJ, Schroeder JC, Pobst LJ, Naylor S, Reid JM, Kaufmann SH, Ames MM (2002) Activation of the antitumor agent aminoflavone (NSC 686288) is mediated by induction of tumor cell cytochrome P450 1A1/1A2. Mol Pharmacol 62(1):143–153
Loaiza-Perez AI, Kenney S, Boswell J, Hollingshead M, Alley MC, Hose C, Ciolino HP, Yeh GC, Trepel JB, Vistica DT, Sausville EA (2004) Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells. Mol Cancer Ther 3(6):715–725
McLean L, Soto U, Agama K, Francis J, Jimenez R, Pommier Y, Sowers L, Brantley E (2008) Aminoflavone induces oxidative DNA damage and reactive oxidative species-mediated apoptosis in breast cancer cells. Int J Cancer 122(7):1665–1674
Meng LH, Kohlhagen G, Liao ZY, Antony S, Sausville E (2005) DNA-protein cross-links and replication-dependent histone H2AX phosphorylation induced by aminoflavone (NSC 686288), a novel anticancer agent active against human breast cancer cells. Cancer Res 65(12):5337–5343
Nijveldt RJ, Van Nood E, Van Hoorn DE, Boelens PG, Van Norren K, Van Leeuwen PA (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74(4):418–425
Nitin NA, Soni PA (2005) Reaction of 2′-hydroxy-5′-acetamidochalcones with dimethyl sulfoxide-iodine, pyridine-mercuric(II) acetate and triethanolamine. Indian J Chem 44B:2601–2603
Ren W, Qiao Z, Wang H, Zhu L, Zhang L (2003) Flavonoids: promising anticancer agents. Med Res Rev 23(4):519–534
Scambia G, Ranelletti FO, Benedetti P, Panici R, Vincenzo G, Bonanno G, Ferrandina, Piantelli MS, Bussa CR, Cianfriglia M (1994) Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: p-glycoprotein as a possible target. Cancer Chemother Pharmacol 34(6):459–464
Skehan P, Storeng R, Scudiero D, Monks A, Mc Mohan J, Vistica D, Warren JT, Bokesch H, Kenny S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82(13):1107–1112
Stefani ED, Boffetta P, Deneo-Pellegrini H, Mendilaharsu M, Carzoglio JC, Ronco A, Olivera L (1999) Dietary antioxidants and lung cancer risk: a case-control study in Uruguay. Nutr Cancer 34(1):100–110
Telford WG, King LE, Fraker PJ (1991) Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif 24(5):447–459
Telford WG, King LE, Fraker PJ (1992) Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry 13(2):137–143
Winter CA, Risley EA, Nuss GW (1962) Carrageenan induced edema in hind paw of rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 111:544–547
Acknowledgments
The authors would like to acknowledge the All India Council for Technical Education (AICTE) of New Delhi for funding this work under Quality Improvement Programme (QIP). The authors would also like to thank Dr. Annapurni Rangarajan from the Department of Molecular Reproduction Development and Genetics (MRDG) at the Indian Institute of Science in Bangalore for providing the facility to perform the cytotoxicity assays, and the Hoechst staining and flow cytometric FACS analyses. The authors would also like to acknowledge the NMR Research centre at the Indian Institute of Science IISC in Bangalore for the NMR spectral data.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moorkoth, S., Srinivasan, K.K., Gopalan Kutty, N. et al. Synthesis and evaluation of a series of novel imidazolidinone analogues of 6-aminoflavone as anticancer and anti-inflammatory agents. Med Chem Res 22, 5066–5075 (2013). https://doi.org/10.1007/s00044-013-0486-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-013-0486-7